Paper
0
Associations of Urine and Plasma Metabolites with Kidney Failure and Death in a CKD Cohort
Authors
Inga Steinbrenner,Ulla Schultheiß
Helena Bächle,Chang‐Feng Dai,Charlotte Behning,Matthias Schmid,Wan-Jin Yeo,Bing Yu,Morgan Grams,Pascal Schlosser,Helena Stockmann,Wolfram Gronwald,Florian Kronenberg,Elke Schaeffner,Kai‐Uwe Eckardt,Michael Köttgen,Peggy Sekula,Heike Meiselbach,Markus Schneider,Mario Schiffer,Hans‐Ulrich Prokosch,Barbara Kollerits,Andreas Beck,André Reis,Arif Ekici,Susanne Becker,Ulrike Alberth-Schmidt,Anke Weigel,Sabine Marschall,Eugenia Schefler,Gerd Walz,Fruzsina Kotsis,Simone Meder,Erna Mitsch,Ursula Reinhard,Jürgen Floege,Turgay Saritas,Alice Groß,Seema Baid‐Agrawal,Kerstin Theisen,Kai Schmidt‐Ott,Martin Zeier,Claudia Sommerer,Mehtap Aykac,Günter Wolf,Martin Busch,Andy Steiner,Thomas Sitter,Christoph Wanner,Vera Krane,Antje Börner-Klein,Britta Bauer,Julia Raschenberger,Lukas Forer,Sebastian Schönherr,Hansi Weißensteiner
+54 authors
,Jennifer NadalPublished
May 28, 2024
Show more
Save
Tip0
TipSave
Abstract
Biomarkers that enable better identification of persons with chronic kidney disease (CKD) who are at higher risk for disease progression and adverse events are needed. This study sought to identify urine and plasma metabolites associated with progression of kidney disease.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.